184 related articles for article (PubMed ID: 15901990)
1. Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk.
Park JY; Chen L; Elahi A; Lazarus P; Tockman MS
Eur J Cancer Prev; 2005 Jun; 14(3):223-30. PubMed ID: 15901990
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County.
London SJ; Smart J; Daly AK
Lung Cancer; 2000 May; 28(2):147-55. PubMed ID: 10717332
[TBL] [Abstract][Full Text] [Related]
3. Epoxide hydrolase genotype and orolaryngeal cancer risk: interaction with GSTM1 genotype.
Park JY; Schantz SP; Lazarus P
Oral Oncol; 2003 Jul; 39(5):483-90. PubMed ID: 12747973
[TBL] [Abstract][Full Text] [Related]
4. Exon 5 polymorphisms in the O6-alkylguanine DNA alkyltransferase gene and lung cancer risk in non-smokers exposed to second-hand smoke.
Cohet C; Borel S; Nyberg F; Mukeria A; Brüske-Hohlfeld I; Constantinescu V; Benhamou S; Brennan P; Hall J; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):320-3. PubMed ID: 14973087
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
6. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in the
Walia HK; Singh N; Sharma S
Future Oncol; 2021 Dec; 17(35):4925-4946. PubMed ID: 34672683
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD.
Park JY; Chen L; Wadhwa N; Tockman MS
Int J Mol Med; 2005 Mar; 15(3):443-8. PubMed ID: 15702235
[TBL] [Abstract][Full Text] [Related]
9. Association between environmental tobacco smoke exposure and lung cancer susceptibility: modification by antioxidant enzyme genetic polymorphisms.
Fathy M; Hamed M; Youssif O; Fawzy N; Ashour W
Mol Diagn Ther; 2014 Feb; 18(1):55-62. PubMed ID: 23928928
[TBL] [Abstract][Full Text] [Related]
10. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
11. EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.
Dura P; Bregitha CV; Te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
Oncol Rep; 2012 Jun; 27(6):1710-6. PubMed ID: 22447130
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
Habalová V; Salagovic J; Kalina I; Stubna J
Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility.
Sunaga N; Kohno T; Yanagitani N; Sugimura H; Kunitoh H; Tamura T; Takei Y; Tsuchiya S; Saito R; Yokota J
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):730-8. PubMed ID: 12163326
[TBL] [Abstract][Full Text] [Related]
14. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.
Zhou W; Thurston SW; Liu G; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):461-6. PubMed ID: 11352855
[TBL] [Abstract][Full Text] [Related]
15. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.
Miller DP; De Vivo I; Neuberg D; Wain JC; Lynch TJ; Su L; Christiani DC
Int J Cancer; 2003 May; 104(6):758-63. PubMed ID: 12640684
[TBL] [Abstract][Full Text] [Related]
16. Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk.
To-Figueras J; Gené M; Gómez-Catalán J; Piqué E; Borrego N; Caballero M; Cruellas F; Raya A; Dicenta M; Corbella J
Cancer Lett; 2002 Dec; 187(1-2):95-101. PubMed ID: 12359356
[TBL] [Abstract][Full Text] [Related]
17. The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans.
Wu X; Gwyn K; Amos CI; Makan N; Hong WK; Spitz MR
Carcinogenesis; 2001 Jun; 22(6):923-8. PubMed ID: 11375900
[TBL] [Abstract][Full Text] [Related]
18. Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk.
Gsur A; Zidek T; Schnattinger K; Feik E; Haidinger G; Hollaus P; Mohn-Staudner A; Armbruster C; Madersbacher S; Schatzl G; Trieb K; Vutuc C; Micksche M
Br J Cancer; 2003 Aug; 89(4):702-6. PubMed ID: 12915882
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.
Yin L; Pu Y; Liu TY; Tung YH; Chen KW; Lin P
Lung Cancer; 2001; 33(2-3):133-41. PubMed ID: 11551408
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis.
Erkisi Z; Yaylim-Eraltan I; Turna A; Görmüs U; Camlica H; Isbir T
Tumori; 2010; 96(5):756-63. PubMed ID: 21302624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
